Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
X3EM Brands is a consumer healthcare company focused on the development and commercialization of innovative first aid and wound care solutions. The company's core technology centers on advanced hemostatic agents that facilitate rapid blood clotting and wound protection for minor injuries. Their product portfolio, marketed under the X3EM brand, includes hemostatic sprays and specialized bandages designed for both consumer and professional use. By leveraging proprietary formulations, X3EM Brands aims to provide effective, easy-to-use alternatives to traditional wound care methods in the over-the-counter market. The company primarily targets the retail sector, distributing its products through major pharmacy chains and big-box retailers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on X3EM Brands.